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Faculty of Biotechnology, University
of Wrocław ul. F. Joliot-Curie 14a,
50383 Wrocław, PolandIt is my great pleasure to announce the launch of a new alliance between our journal,
Cellular and Molecular Biology Letters (CMBL), and an international publisher, BioMed
Central (part of Springer Nature). This event opens the 21st year of publication of our
journal and changes the model of publication to an open system. Therefore, I would like
to take this occasion to thank my colleagues, Professors Jan Szopa and Arkadiusz
Kozubek* and Ms Małgorzata Nietubyć for a wonderful 20 years of a lasting and
common effort to publish the journal. I remember, in particular, the pioneering years,
when we started the journal without financial support and with rather weak institutional
help when conditions were very challenging. Without their help, support and contribu-
tion throughout this formative period, this venture would not have been possible.
I would like to thank all of our authors and readers who supported our initiative
since its start in 1996. Of great importance was the tireless effort of the reviewers in
taking care of the standards of the publications. Their contribution has been inva-
luable. The contributions of the first Editorial Board Members who helped us a lot
through their advice, in particular our colleagues, Professors Stanisław Przestalski,
Tadeusz Chojnacki and Włodzimierz Korohoda, have been greatly appreciated.
Our journal is published by the University of Wrocław, in collaboration with the
Polish Society for Cell Biology, along with more than 15 years of lasting support from
the Polish Ministry of Scientific Research and Higher Education. I would like to take
this occasion to express our gratitude to these institutions.
Of course, the greatest support that we received was from all of our contributors
who submitted work of such a standard that we were able to enter world-wide
databases, in particular, the ISI Web of Science, so quickly. The quality of the contri-
butions is reflected in the recently published Impact Factor for the journal, which is
1.753 for the past year, along with a five-year Impact Factor of 1.681.
CMBL is a forum for researchers, covering the broad areas of cell and molecular
biology, including: the cell cycle and its regulation, cell differentiation, cell traffic and
signaling, stem cells, gene expression regulation, cellular membranes, cytoskeleton and
molecular biotechnology, not excluding other aspects of studies such as cellular
proteomics, genomics and advanced imaging technologies. Research, review, short
report and mini-review articles are all welcome.
Although our journal has developed well and to the point that it now has a small,
but stable, circle of authors and readers, we have considered now for quite some time
on how to get into an open access model of publication. Now, through establishing the© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International
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this opportunity. Therefore, we hope that, with this new arrangement, the journal will
continue to grow in its readership as well as upon its impact within the scientific
community that it is trying to reach. Fortunately, the open access journals have become
a standard vehicle of publication of the newest achievements of the research in cell and
molecular biology. Both the Editorial Team and I, believe that the choice we have made
are vital for the future of the journal and that we will be successful in achieving our
goal. However, we still need the support of all of you, both our authors and our readers,
in this.
With this move towards open access comes also a change in the way that the journal
will charge for its services, with the introduction of a single flat-fee as an article
processing charge (APC) for successful manuscripts. This is an inevitable part of the
process of open access publishing, where the costs associated with an open access
format are covered by the APC. We believe that, overall, this charge structure repre-
sents a cost-effective publishing route, especially when the wider reach of the open
access format will bring manuscripts to the attention of a much larger audience, with a
corresponding increase in weighting in the impact factor. On behalf of the Editorial
team, I promise that our priority is the quality of research presented by the manuscripts
it publishes, its novelty, technical advance and importance in learning molecular
mechanisms underlying normal and pathological cell biology. All manuscripts will be
treated equally, honestly peer-reviewed and published as soon as they will be accepted.
So, we invite you all, as authors, to publish with us.
We trust that our authors will be satisfied with the publication service they receive
from our Editorial Office and BioMed Central. It is my strong belief that this alliance
will secure the stable progress of the journal and help it make a greater impact in the
field of the molecular biology of the cell. I also hope very much that it will continue to
provide a friendly vehicle for the publication of important and significant achievements
in global research towards progress in learning about how cells function.
Editor-in-Chief, Cellular and Molecular Biology Letters
*Sadly, passed away on May 20, 2016
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